# Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

> **NCT06006637** · NA · RECRUITING · sponsor: **State University of New York - Upstate Medical University** · enrollment: 80 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DEVICE:** Cognilum TM: Light Treatment Condition

## Key facts

- **NCT ID:** NCT06006637
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-17
- **Primary completion:** 2026-08-15
- **Final completion:** 2026-08-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-10-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06006637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06006637, "Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06006637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*